#BEGIN_DRUGCARD DB04022

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
17633

# Chemical_Formula:
C10H17N5O17P4

# Chemical_IUPAC_Name:
[({[(2S,3R,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-4-hydroxy-3-{[hydroxy(phosphonooxy)phosphoryl]oxy}oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Guanosine 5&#39;-diphosphate 2&#39;(3&#39;)-diphosphate. A guanine nucleotide containing four phosphate groups. Two phosphate groups are esterified to the sugar moiety in the 5&#39; position and the other two in the 2&#39; or 3&#39; position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis. Synonym: magic spot I. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Guanosine-5',3'-Tetraphosphate

# HET_ID:
G4P

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H17N5O17P4/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6(30-36(26,27)32-34(21,22)23)3(29-9)1-28-35(24,25)31-33(18,19)20/h2-3,5-6,9,16H,1H2,(H,24,25)(H,26,27)(H2,18,19,20)(H2,21,22,23)(H3,11,13,14,17)/t3-,5+,6-,9+/m0/s1

# InChI_Key:
InChIKey=BUFLLCUFNHESEH-FULWYAMNSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4022

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
603.1603

# Molecular_Weight_Mono:
602.956990191

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1Y0B

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.29

# Predicted_LogS:
-1.9

# Predicted_Water_Solubility:
8.42e+00 g/l

# Primary_Accession_No:
DB04022

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936862

# PubChem_Substance_ID:
46508997

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01534

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC2=C(N=CN2[C@@H]2O[C@@H](CO[P@](O)(=O)OP(O)(O)=O)[C@H](O[P@](O)(=O)OP(O)(O)=O)[C@H]2O)C(=O)N1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:52 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X83878

# Drug_Target_1_GenBank_ID_Protein:
633169

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
xpt

# Drug_Target_1_Gene_Sequence:
>585 bp
ATGGAAGCACTGAAACGGAAAATAGAGGAAGAAGGCGTCGTATTATCTGATCAGGTATTG
AAAGTGGATTCTTTTTTGAATCACCAAATTGATCCGCTGCTTATGCAGAGAATTGGTGAT
GAATTTGCGTCTAGGTTTGCAAAAGACGGTATTACCAAAATTGTGACAATCGAATCATCA
GGTATCGCTCCCGCTGTAATGACGGGCTTGAAGCTGGGTGTGCCAGTTGTCTTCGCGAGA
AAGCATAAATCGTTAACACTCACCGACAACTTGCTGACAGCGTCTGTTTATTCCTTTACG
AAGCAAACAGAAAGCCAAATCGCAGTGTCTGGGACCCACCTGTCGGATCAGGATCATGTG
CTGATTATCGATGATTTTTTGGCAAATGGACAGGCAGCGCACGGGCTTGTGTCGATTGTG
AAGCAAGCGGGAGCTTCTATTGCGGGAATCGGCATTGTTATTGAAAAGTCATTTCAGCCG
GGAAGAGATGAACTTGTAAAACTGGGCTACCGAGTGGAATCTTTGGCAAGAATTCAGTCT
TTAGAAGAAGGAAAAGTGTCCTTCGTACAGGAGGTTCATTCATGA

# Drug_Target_1_General_Function:
Nucleotide transport and metabolism

# Drug_Target_1_General_References:
9098051	Christiansen LC, Schou S, Nygaard P, Saxild HH: Xanthine metabolism in Bacillus subtilis: characterization of the xpt-pbuX operon and evidence for purine- and nitrogen-controlled expression of genes involved in xanthine salvage and catabolism. J Bacteriol. 1997 Apr;179(8):2540-50.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3300

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
21038

# Drug_Target_1_Name:
Xanthine phosphoribosyltransferase

# Drug_Target_1_Number_of_Residues:
194

# Drug_Target_1_PDB_ID:
1Y0B

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00156	Pribosyltran

# Drug_Target_1_Protein_Sequence:
>Xanthine phosphoribosyltransferase
MEALKRKIEEEGVVLSDQVLKVDSFLNHQIDPLLMQRIGDEFASRFAKDGITKIVTIESS
GIAPAVMTGLKLGVPVVFARKHKSLTLTDNLLTASVYSFTKQTESQIAVSGTHLSDQDHV
LIIDDFLANGQAAHGLVSIVKQAGASIAGIGIVIEKSFQPGRDELVKLGYRVESLARIQS
LEEGKVSFVQEVHS

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
P42085

# Drug_Target_1_SwissProt_Name:
XPT_BACSU

# Drug_Target_1_Synonyms:
EC 2.4.2.-

# Drug_Target_1_Theoretical_pI:
6.24

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
M24537

# Drug_Target_2_GenBank_ID_Protein:
508979

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
obg

# Drug_Target_2_Gene_Sequence:
>1287 bp
ATGTTTGTAGATCAGGTCAAAGTATATGTAAAAGGCGGCGACGGCGGCAACGGTATGGTT
GCGTTTCGCCGTGAAAAATATGTGCCGAAAGGCGGCCCTGCCGGCGGTGACGGAGGAAAG
GGAGGAGACGTCGTTTTTGAAGTAGATGAAGGTCTCCGCACCCTGATGGATTTTAGATAC
AAAAAACACTTTAAAGCGATTCGCGGCGAGCATGGCATGTCCAAAAACCAGCACGGGCGA
AATGCTGATGATATGGTCATTAAAGTTCCGCCGGGCACCGTTGTGACAGACGATGATACA
AAACAGGTCATCGCTGATTTAACAGAGCACGGACAGCGGGCTGTCATTGCAAGAGGCGGA
AGAGGCGGAAGAGGAAATAGCCGCTTTGCTACACCGGCTAATCCCGCGCCTCAGCTTTCA
GAAAACGGCGAGCCGGGAAAAGAACGCTACATTGTTCTTGAATTAAAAGTGCTTGCAGAT
GTCGGACTTGTCGGGTTCCCGAGTGTGGGAAAATCTACTTTGCTGTCTGTTGTCTCATCT
GCAAAACCGAAAATTGCGGACTATCACTTTACAACGCTTGTCCCGAATCTCGGCATGGTT
GAAACGGATGACGGACGCAGCTTTGTCATGGCTGATTTGCCAGGGCTGATTGAAGGCGCA
CACCAAGGCGTCGGACTGGGCCACCAGTTTTTGCGCCATATTGAACGGACGAGGGTTATT
GTTCATGTCATTGACATGTCAGGCTTAGAAGGCCGTGATCCATATGATGATTATCTTACG
ATTAACCAGGAGCTGAGCGAGTACAATCTGCGTCTCACTGAGCGTCCGCAAATTATCGTT
GCAAATAAAATGGACATGCCGGAGGCTGCGGAAAATCTCGAAGCCTTTAAAGAAAAGCTG
ACGGATGATTATCCGGTATTCCCGATCAGTGCGGTGACAAGAGAAGGTCTGCGTGAGCTT
CTGTTTGAGGTTGCCAATCAGCTTGAGAACACACCGGAATTCCCGCTGTATGACGAGGAA
GAGCTTACACAAAACCGTGTCATGTACACGATGGAAAATGAAGAAGTGCCATTTAACATT
ACACGCGATCCAGACGGTGTATTTGTGCTTTCAGGAGACAGCCTTGAGCGGTTATTCAAG
ATGACTGATTTCTCACGTGATGAATCGGTTAAACGGTTTGCAAGACAGATGCGCGGAATG
GGTGTTGATGAAGCACTCAGAGAACGCGGAGCCAAGGATGGAGATATAATCAGGCTTCTG
GAATTTGAATTTGAATTTATTGATTAA

# Drug_Target_2_General_Function:
Involved in GTP binding

# Drug_Target_2_General_References:
2537815	Trach K, Hoch JA: The Bacillus subtilis spo0B stage 0 sporulation operon encodes an essential GTP-binding protein. J Bacteriol. 1989 Mar;171(3):1362-71.
3918016	Ferrari FA, Trach K, Hoch JA: Sequence analysis of the spo0B locus reveals a polycistronic transcription unit. J Bacteriol. 1985 Feb;161(2):556-62.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3273

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
47690

# Drug_Target_2_Name:
Spo0B-associated GTP-binding protein

# Drug_Target_2_Number_of_Residues:
428

# Drug_Target_2_PDB_ID:
1LNZ

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01018	GTP1_OBG
PF01926	MMR_HSR1
PF09269	DUF1967

# Drug_Target_2_Protein_Sequence:
>Spo0B-associated GTP-binding protein
MFVDQVKVYVKGGDGGNGMVAFRREKYVPKGGPAGGDGGKGGDVVFEVDEGLRTLMDFRY
KKHFKAIRGEHGMSKNQHGRNADDMVIKVPPGTVVTDDDTKQVIADLTEHGQRAVIARGG
RGGRGNSRFATPANPAPQLSENGEPGKERYIVLELKVLADVGLVGFPSVGKSTLLSVVSS
AKPKIADYHFTTLVPNLGMVETDDGRSFVMADLPGLIEGAHQGVGLGHQFLRHIERTRVI
VHVIDMSGLEGRDPYDDYLTINQELSEYNLRLTERPQIIVANKMDMPEAAENLEAFKEKL
TDDYPVFPISAVTREGLRELLFEVANQLENTPEFPLYDEEELTQNRVMYTMENEEVPFNI
TRDPDGVFVLSGDSLERLFKMTDFSRDESVKRFARQMRGMGVDEALRERGAKDGDIIRLL
EFEFEFID

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Essential GTP-binding protein

# Drug_Target_2_SwissProt_ID:
P20964

# Drug_Target_2_SwissProt_Name:
OBG_BACSU

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
4.80

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04022
